Contact
Departments & Divisions
Research
Clinical
Rebecca Romero, MD
Associate Professor/Clinical
-
Professional Background
Education
- 2004 - MD - Medicine and Surgery - University of Texas Health Science Center at San Antonio
- 2000 - BA - Biology with emphasis Chemistry & Psychology (Summa Cum Laude) - Rice University, Houston, TX
Training
- 2011 - Fellowship - Multiple Sclerosis/Clinical Neuroimmunology - University of Chicago, IL
- 2008 - Residency - Neurology - University of Texas Health Science Center at San Antonio
- 2005 - Internship - Internal Medicine - University of Texas Health Science Center at San Antonio
Highlights
06/2019 Texas Super Doctors
04/2018 Fellow of the American Academy of Neurology
02/2018 San Antonio Magazine Best Doctors in San Antonio
09/2017 Diane Solomon MD Award for Excellence in Teaching: UT Health San Antonio, Neurology Medical StudentsAppointments
- 2019-present - Associate Professor / Clinical - UT Health San Antonio, Department of Neurology, San Antonio, TX
- 2018-present - Associate Residency Program Director - UT Health San Antonio, Department of Neurology, San Antonio, TX
- 09/2011-03/2019 - Assistant Professor/Clinical - UT Health San Antonio, Department of San Antonio, San Antonio, TX
-
Instruction & Training
- 01/2011-present, 2nd Year Medical Student Lecture "Multiple Sclerosis", UT Health San Antonio
-
Research & Grants
Multiple Sclerosis and Clinical Neuroimmunology - Clinical Neuroimmunology is an ever expanding subspecialty of Neurology. Multiple Sclerosis, Neuromyelitis Optica, Autoimmune encephalitis and related diseases are increasingly recognized and discovered around the world. My focus is on the diagnosis (clinically and radiologically), treatment, and management of patients throughout their lives.
Grants
07/2016-Present
Funding Agency: Alexion
Title: ECU-NMO-302 A phase III, open-label, extension trial of ECU-NMO-301 to evaluate the safety and efficacy of Eculizumab in patients with relapsing Neuromyelitis Optica (NMO).
Role: Principal Investigator07/2016-08/2018
Funding Agency: Alexion
Title: ECU-NMO-301 A Randomized, double-blind, placebo-controlled multicenter trial to evaluate the safety and efficacy of Ezulizumab in patients with relapsing Neuromyelitis Optica (NMO).
Role: Principal Investgator06/2014-present
Funding Agency: Chugai
Title: Chugai SA-309JG NMO/NMOSD Study
Role: Principal Investigator -
Service
Department
01/2018-Present Associate Residency Program Director
09/2011-Present Director of Multiple Sclerosis and Clinical Neuroimmunology Clinic
07/2018-Present Advising and Mentoring - Kyna Schreiber MD
01/2017-Present Program Evaluation Committee
07/2017-Present Advising and Mentoring - Noor Shahid MD
07/2017-Present Advising and Mentoring - Justin Rodriguez MD PhD
01/2016-Present Advising and Mentoring - Florence Yi Yi Ling Chang MD
01/2014-Present Clinical Competency CommitteeNational
04/2017-Present Frontiers in Neurology Journal (Editorial Board Member)
01/2013-Present National Multiple Sclerosis Clinical Advisory Committee (Member)
09/2011-Present Journal of Neurological Sciences (Reviewer)
01/2011-Present American Academy of Neurology on the Hill Attendee (Invited Participant) -
Publications
-
Clinical
Board Certifications
- 2008 - Neurology - American Board of Psychiatry and Neurology